Project documents | Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 158 KB)

Published:

10 June 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 249 KB)

Published:

10 June 2025
Equality impact assessment (scoping) (PDF 108 KB)

Published:

10 June 2025
Supporting documentation (downloadable version) (PDF 185 KB)

Published:

17 June 2025
Final stakeholder list (PDF 53 KB)

Published:

24 June 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6441

Review proposal paper (PDF 265 KB)

Published:

27 February 2025
Draft scope post referral (PDF 237 KB)

Published:

27 February 2025
Draft matrix post referral (PDF 54 KB)

Published:

10 March 2025

Referral

Referral

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6441

Draft scope post referral (PDF 189 KB)

Published:

25 July 2024
Draft matrix post referral (PDF 180 KB)

Published:

30 July 2024

Topic selection

Topic selection